This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
As a class-action lawsuit gets rolling in California over the use of ambient AI in healthcare, a national law firm is drawing takeaways for hospitals and other provider organizations. Makes sense: All AI-equipped providers are potential targets for similar litigation now.
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized.
In hospitals serving mentally unstable patients, it’s no easy job to balance sensitive patient treatment with effective worker safety. One U.S. institution has been finding out just how hard it can be.
Manufacturer ICU Medical is aware of the issue, which stems from a report from an unnamed healthcare organization. The company and the FDA are asking providers to monitor IV lines for any signs of particulates.
The suggestion comes from a strategic communications professional who specializes in thinking creatively about how to unlock opportunities—including those that are, at present, hard to see.
Querying 55 thought leaders behind closed doors, the Stanford Institute for Human-Centered AI has found only 12% believe healthcare AI should always have a human in the loop.
Care teams are always looking for new ways to limit the use of permanent pacemakers after TAVR. Could starting patients off with temporary devices be an answer?
When it comes to adopting healthcare AI, large, well-off hospitals are likely to frequently homer while smaller, struggling institutions go down looking. (Baseball analogy in honor of tonight’s Midsummer Classic.)